Long-term efficacy of continuous baricitinib treatment in patients with severe alopecia areata: 3-year results from BRAVE-AA1 and BRAVE-AA2; Supplementary Material

Name: Long-term efficacy of continuous baricitinib treatment in patients with severe alopecia areata: 3-year results from BRAVE-AA1 and BRAVE-AA2; Supplementary Material
Creator: Maryanne Senna
Published: 2025-11-13T21:35:57.594Z
Keywords: Clinical Trial, Alopecia Areata

Senna, Maryanne; Mostaghimi, Arash; Sinclair, Rod; Ohyama, Manabu; Chiasserini, Chiara; Yu, Guanglei; Liu, Chunyuan; Somani, Najwa; Ball, Susan; Kolodsick, Jill; King, Brett

doi:10.17632/93nryjvxz4.1

Long-term efficacy of continuous baricitinib treatment in patients with severe alopecia areata: 3-year results from BRAVE-AA1 and BRAVE-AA2; Supplementary Material

Published: 13 November 2025| Version 1 | DOI: 10.17632/93nryjvxz4.1

Contributors:

Maryanne Senna, Arash Mostaghimi, Rod Sinclair, Manabu Ohyama, Chiara Chiasserini, Guanglei Yu, Chunyuan Liu, Najwa Somani, Susan Ball, Jill Kolodsick, Brett King

Description

Supplementary Material associated with the manuscript Long-term efficacy of continuous baricitinib treatment in patients with severe alopecia areata: 3-year results from BRAVE-AA1 and BRAVE-AA2 published in JAAD.

Long-term efficacy of continuous baricitinib treatment in patients with severe alopecia areata: 3-year results from BRAVE-AA1 and BRAVE-AA2; Supplementary Material

Description

Files

Institutions

Categories

Funders

Licence